Rezultati pretraživanja
  1. 9 in 10 Americans support ↑ research-bipartisan support overwhelming [Mar 25, 2016] HT

  2. prije 17 sati

    Results from the registered trial investigating sun protection education for teenagers can be found at: see the trial record here:

  3. 4. velj

    Positive results for anifrolumab in phase III SLE trial

  4. 4. velj

    Pfizer, J&J and Amgen are among the big drugmakers that have sought approval for drugs based on data mined from real-world health records via

  5. 4. velj

    "China has begun clinical trials to test a drug for the deadly new coronavirus, which has no cure and is being treated with a combination of antivirals and other measures"

  6. 4. velj

    HPV-Cancer Targeting Immunotherapy Enters Phase 1 Clinical Trial After Showing Success In Animals l Forbes

  7. 4. velj

    Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

  8. 4. velj

    Would you take a drug discovered by artificial intelligence? Interesting question with huge impact on

  9. 3. velj

    Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma

  10. 3. velj

    Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study

  11. 3. velj

    BBC News - Artificial intelligence-created medicine to be used on humans for first time

  12. 2. velj

    Gilead Sciences said it is sending an experimental antiviral drug to China for emergency treatment of coronavirus patients as well as testing to see if it works against the virus via

  13. 1. velj

    Excited to see artificial intelligence assisting scientists and clinicians speed up the process of drug discovery

  14. 1. velj

    Multi-drug therapy for epilepsy influenced bispectral index after a bolus propofol administration without affecting propofol’s pharmacokinetics: a prospective cohort study

  15. 31. sij

    CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations

  16. 31. sij

    CD40 blockade shows promise in pSS trial

  17. 31. sij
  18. 30. sij

    Pharmalittle: Combining antibiotics may cause resistance; Lilly moves into dermatitis market with $1.1 billion deal.

  19. 29. sij

    Room for improvement in clinical trials for rare diseases

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.